Itron (NASDAQ:ITRI) SVP John Marcolini Sells 267 Shares

Itron, Inc. (NASDAQ:ITRI) SVP John Marcolini sold 267 shares of the stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $79.60, for a total value of $21,253.20. Following the completion of the sale, the senior vice president directly owned 25,011 shares of the company’s stock, valued at approximately $1,990,875.60. This represents a 1.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Stock Up 0.6%

Shares of Itron stock opened at $81.85 on Friday. The stock has a 50-day moving average price of $88.63 and a 200 day moving average price of $94.60. The company has a market cap of $3.63 billion, a P/E ratio of 13.05, a P/E/G ratio of 0.71 and a beta of 1.35. The company has a current ratio of 2.66, a quick ratio of 2.24 and a debt-to-equity ratio of 0.97. Itron, Inc. has a 1 year low of $77.77 and a 1 year high of $142.00.

Itron (NASDAQ:ITRI) last announced its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.23. The firm had revenue of $586.98 million during the quarter, compared to the consensus estimate of $572.04 million. Itron had a return on equity of 19.54% and a net margin of 12.31%.The business’s revenue for the quarter was down 3.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.52 EPS. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. As a group, analysts expect that Itron, Inc. will post 6.01 EPS for the current fiscal year.

Trending Headlines about Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Stephens reaffirmed its Overweight rating on Itron and kept a $130 price target, implying substantial upside from the current share price. Stephens reaffirms Overweight on Itron
• Neutral Sentiment: Several Itron executives sold small blocks of shares, but the filings say the transactions were mainly to cover tax withholding from equity award vesting, which makes the insider activity less concerning than open-market selling. SEC filing for insider sale
• Negative Sentiment: Zacks Research cut multiple earnings estimates for Itron, including a sharp reduction for Q4 2027 and a lower FY2027 forecast, signaling softer profit expectations ahead. Zacks Research estimate cuts for Itron

Analyst Ratings Changes

Several equities research analysts recently issued reports on ITRI shares. JPMorgan Chase & Co. reduced their price objective on Itron from $133.00 to $113.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Oppenheimer upped their target price on Itron from $133.00 to $135.00 and gave the stock an “outperform” rating in a research report on Thursday, April 16th. Zacks Research raised Itron from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 26th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Itron in a research report on Friday, May 8th. Finally, TD Cowen dropped their target price on Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $131.22.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. California State Teachers Retirement System increased its holdings in shares of Itron by 28.3% during the 1st quarter. California State Teachers Retirement System now owns 55,042 shares of the scientific and technical instruments company’s stock valued at $4,933,000 after acquiring an additional 12,154 shares during the last quarter. Entropy Technologies LP increased its holdings in shares of Itron by 6.3% during the 1st quarter. Entropy Technologies LP now owns 8,278 shares of the scientific and technical instruments company’s stock valued at $742,000 after acquiring an additional 490 shares during the last quarter. Renaissance Technologies LLC increased its holdings in shares of Itron by 10.1% during the 1st quarter. Renaissance Technologies LLC now owns 461,761 shares of the scientific and technical instruments company’s stock valued at $41,388,000 after acquiring an additional 42,300 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in shares of Itron by 12.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 673,420 shares of the scientific and technical instruments company’s stock valued at $60,359,000 after acquiring an additional 73,020 shares during the last quarter. Finally, Caxton Associates LLP acquired a new position in shares of Itron during the 1st quarter valued at about $2,212,000. Institutional investors and hedge funds own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.